title: Immunomodulatory therapy to achieve maximum efficacy: doses, monitoring, compliance, and self-infusion at home.
abstract: BACKGROUND
  The Oxford Programme for Immunomodulatory Immunoglobulin Therapy has been operating since 1992 at Oxford Radcliffe Hospitals in the UK. Initially, this program was set up for patients with multifocal motor neuropathy or chronic inflammatory demyelinating poly-neuropathy to receive reduced doses of intravenous immunoglobulin (IVIG) in clinic on a regular basis (usually every 3 weeks). The program then rapidly expanded to include self-infusion at home, which monitoring showed to be safe and effective. It has been since extended to the treatment of other autoimmune diseases in which IVIG has been shown to be efficacious.
  
  
  METHODS
  This review includes details of the program such as the training of patients, dosing with immunoglobulin, and monitoring and compliance for self-infusion at home, with cases to illustrate these points.
  
  
  RESULTS
  In addition, the Evidence for efficacy and the effects of confounding morbidities will be are included described. More recently, subcutaneous immunoglobulin therapy (SCIG) has been used in several chronic autoimmune peripheral neuropathies and in epidermolysis bullosa acquisita, with equally good effect. Trials of SCIG in other autoimmune diseases are planned.
authors.affiliation: Department of Clinical Immunology, John Radcliffe Hospital, Level 4A, Oxford, UK.
authors.forename: Mary
authors.initials: M
authors.lastname: Lucas
authors.forename: Ken
authors.initials: K
authors.lastname: Hugh-Jones
authors.forename: Angela
authors.initials: A
authors.lastname: Welby
authors.forename: Siraj
authors.initials: S
authors.lastname: Misbah
authors.forename: Peter
authors.initials: P
authors.lastname: Spaeth
authors.forename: Helen
authors.initials: H
authors.lastname: Chapel
mesh_terms: D000293:Adolescent; D000328:Adult; D020274:Autoimmune Diseases of the Nervous System / Q000276:immunology / Q000628:therapy*; D004306:Dose-Response Relationship, Immunologic; D016903:Drug Monitoring; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage / Q000627:therapeutic use*; D007155:Immunologic Factors / Q000008:administration & dosage / Q000627:therapeutic use*; D007262:Infusions, Intravenous; D007279:Injections, Subcutaneous; D008297:Male; D008875:Middle Aged; D016472:Motor Neuron Disease / Q000628:therapy; D010044:Outpatient Clinics, Hospital; D010349:Patient Compliance; D020277:Polyradiculoneuropathy, Chronic Inflammatory Demyelinating / Q000628:therapy; D011247:Pregnancy; D011644:Puerperal Disorders / Q000276:immunology / Q000628:therapy; D012008:Recurrence; D012646:Self Administration; D008258:Waldenstrom Macroglobulinemia / Q000150:complications / Q000188:drug therapy / Q000628:therapy
chemical_list: D007074:Immunoglobulin G; D016756:Immunoglobulins, Intravenous; D007155:Immunologic Factors
references.citation: Cochrane Database Syst Rev. 2005 Apr 18;(2):CD004429
references.pmid: 15846714
references.citation: Acta Neurol Scand. 2005 Aug;112(2):115-25
references.pmid: 16008538
references.citation: Eur J Neurol. 2009 May;16(5):631-8
references.pmid: 19236457
references.citation: Clin Immunol. 2008 Dec;129(3):518-9
references.pmid: 18848500
references.citation: Muscle Nerve. 2005 Jun;31(6):663-80
references.pmid: 15770650
references.citation: J Clin Immunol. 2010 May;30 Suppl 1:S79-83
references.pmid: 20405181
references.citation: J Peripher Nerv Syst. 2009 Jun;14(2):93-100
references.pmid: 19691531
references.citation: J Allergy Clin Immunol. 2010 Jun;125(6):1354-1360.e4
references.pmid: 20471071
references.citation: Clin Rheumatol. 2008 Aug;27(8):1067-8
references.pmid: 18463936
references.citation: J Neurol Neurosurg Psychiatry. 1997 Jul;63(1):106-9
references.pmid: 9221978
references.citation: Expert Rev Neurother. 2009 Jun;9(6):789-95
references.pmid: 19496683
references.citation: Cochrane Database Syst Rev. 2002;(2):CD001797
references.pmid: 12076423
references.citation: J Neurol Neurosurg Psychiatry. 2008 Jan;79(1):93-6
references.pmid: 18079302
references.citation: Clin Lymphoma Myeloma. 2009 Mar;9(1):17-8
references.pmid: 19362962